US Remote Patient Monitoring (RPM) Market worth $29.13 billion by 2030
The report "US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030", is expected to reach USD 29.13 billion by 2030 from USD 16.09 billion in 2025, at a CAGR of 12.6% during the forecast period.
Browse 303 market data Tables and 162 Figures spread through 352 Pages and in-depth TOC on "US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-remote-patient-monitoring-rpm-market-252862303.html
The growing demand for hospital capacity and healthcare personnel in the US is driving the adoption of remote patient monitoring (RPM) solutions. In 2023–2024, national hospital beds were at 75% occupancy, up from 64% over the previous decade. This heightened demand for healthcare services has contributed to a reduction in the number of staffed hospital beds, which has decreased from approximately 802,000 to 674,000 compared to pre-pandemic levels.
Given the growing patient population that requires attention to their healthcare needs, hospitals are prioritizing the implementation of RPM solutions. These technologies enable healthcare institutions to monitor and manage patient conditions remotely, ultimately improving the delivery of patient care.
“The devices segment held the largest share of the US remote patient monitoring (RPM) market, by component, in 2024.”
The US remote patient monitoring market is classified based on component into devices, software, and services. In 2024, the devices component segment held the largest market share in the US remote patient monitoring market. The prominent driving forces for this market include the growing use of wearable technology for ongoing health monitoring, advancements in sensor technology that enable precise data collection, and an increasing demand for tailored and specialized healthcare offerings. In the US, some healthcare plans are promoting the widespread use of remote patient monitoring (RPM) devices. This includes "hospital-at-home" programs implemented by hospitals and healthcare systems, which aim to remotely monitor all discharged patients through wearable technology. In February 2024, GE Healthcare collaborated with Biofourmis to provide patient monitoring both in and out of the hospital. The company used AI analytics tools from Biofourmis and the Virtual Care Platform solution offered by GE Healthcare. The solution will enable the provision of post-acute and at-home monitoring and healthcare for high-risk patients. Such plans help in monitoring and ensuring better health and safety conditions of patients using portable RPM devices.
“The patients segment is expected to register the fastest growth in the US remote patient monitoring (RPM) market, by end user, during the forecast period.”
The US remote patient monitoring (RPM) market is currently experiencing rapid growth. By end user, the patients segment is expected to expand at the fastest rate throughout the forecast period, driven by increasing patient awareness, a rising number of individuals with chronic diseases, and a growing preference for home health services. This demand for home healthcare is primarily driven by advancements in technology, including wearable devices, mobile mHealth (mHealth) apps, and the Internet of Things (IoT). These health technologies enable distance monitoring and facilitate more personalized and effective treatments.
A 2024 study, which employed a retrospective cohort analysis of healthcare, revealed that RPM had a significantly positive impact on the management of hypertension in a large patient population. This emphasizes the potential benefits of remote monitoring for patients with chronic conditions. Additionally, the US remote patient monitoring market is further segmented by application, which includes teleconsultations and telehealth services.
Due to the increasing demand for affordable and convenient healthcare solutions, particularly among the aging population—which is becoming increasingly comfortable with technology—RPM is expected to enhance convenience and provide easier access to healthcare services. This trend is likely to drive significant growth within the patient end-user segment.
Key Players
The key players functioning in the US remote patient monitoring (RPM) market include Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Medtronic (Ireland), GE Healthcare (US), Abbott (US), Oracle (US), Boston Scientific Corporation (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), VitalConnect (US), VivaLNK, Inc. (US), Clear Arch, Inc. (US), Optum, Inc. (Vivifyhealth) (US), Blue Spark Technologies, Inc. (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc. (US), Guangdong Transtek Medical Electronics Co., Ltd. (China), Dexcom (US), CareSimple Inc. (Canada), TimeDoc, Inc. (US), MD Revolution Inc. (US), Optimize Health, Inc. (US), and Health Recovery Solutions (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the US Remote Patient Monitoring (RPM) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
